Concepedia

Kathleen Dugan

KD

Statistics

Publications

8

Citations

788

H-Index

8

Active since

1969

Affiliations

Stanford University(Current)

University of Rochester Medical Center

Albert Einstein College of Medicine

University of Rochester

Moffitt Cancer Center

Kathleen Dugan is an author at Stanford University specializing in medicine, hematology, and pathology.

Top concepts

Publications per year

1969–2004

8

Publications

8

Mitoxantrone, Etoposide, and Cytarabine With or Without Valspodar in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome: A Phase III Trial (E2995)

Peter L. Greenberg, Sandra J. Lee, Ranjana H. Advani et al. · Journal of Clinical Oncology · 2004 · 232 citations · Full text

Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)

Ranjana H. Advani, Hussain I. Saba, Martin S. Tallman et al. · Blood · 1999 · 149 citations

Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)

Ranjana H. Advani, Hussain I. Saba, Martin S. Tallman et al. · Blood · 1999 · 123 citations

Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: A pilot study

H. Joachim Deeg, Jason Gotlib, C Beckham et al. · Leukemia · 2002 · 104 citations

, , +9

Cytomegalovirus Viremia During Campath-1H Therapy for Relapsed and Refractory Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia

Dorothy Nguyen, Thai M. Cao, Kathleen Dugan et al. · Clinical Lymphoma · 2002 · 68 citations

, , +9

1–5 of 8